Urgency of Transparency Regulation and Informed Consent in the Use of AI-Based Medical Chatbots in Indonesia

Main Article Content

Narendra Bintang Khatulistiwa
Aan Platino
Mohamad Rosidi
Aris Prio Agus Santoso

Abstract

The rapid development of artificial intelligence technology has significantly transformed the healthcare sector, including the emergence of AI-based medical chatbots used for diagnosis support, symptom checking, health consultation, and patient education. In Indonesia, the adoption of medical chatbots has increased alongside the expansion of digital health services. However, the legal framework governing transparency obligations and informed consent mechanisms in the operation of AI-based medical chatbots remains fragmented and insufficient. This study analyzes the urgency of establishing comprehensive regulations concerning transparency and informed consent in the use of medical chatbots in Indonesia. The research employs a normative juridical method through statutory, conceptual, and comparative approaches. The study examines Indonesian laws relating to health services, electronic information systems, personal data protection, consumer protection, and medical ethics. The findings indicate that AI-based medical chatbots may create legal uncertainty regarding accountability, patient autonomy, data privacy, algorithmic bias, and medical malpractice risks when transparency and informed consent principles are not adequately regulated. Furthermore, existing regulations have not specifically addressed the obligations of developers and healthcare providers to disclose AI system limitations, decision-making processes, data usage practices, and potential risks to users. Therefore, Indonesia urgently requires a specific and harmonized regulatory framework to ensure legal certainty, patient protection, ethical healthcare innovation, and responsible AI governance. This article recommends the formulation of detailed transparency standards, mandatory informed consent procedures, algorithmic accountability principles, and supervisory mechanisms to support the safe and ethical implementation of AI-based medical chatbots in Indonesia.

Article Details

How to Cite
Khatulistiwa, N. B., Platino, A., Rosidi, M., & Santoso, A. P. A. (2026). Urgency of Transparency Regulation and Informed Consent in the Use of AI-Based Medical Chatbots in Indonesia. The Eastasouth Journal of Social Science and Humanities, 3(03), 546 –551 . https://doi.org/10.58812/esssh.v3i03.1019
Section
Articles

References

[1] L. Floridi, “Establishing the rules for building trustworthy AI,” Nat. Mach. Intell., 2019.

[2] C. Cath, “Governing artificial intelligence: Ethical, legal and technical opportunities and challenges,” 2018.

[3] T. Beauchamp and J. Childress, Principles of Biomedical Ethics. 2019.

[4] I. G. Cohen, “Informed consent and medical artificial intelligence: what to tell the patient,” Georgetown Law J., vol. 108, no. 6, pp. 1425–1469, 2020, [Online]. Available: https://www.law.georgetown.edu/georgetown-law-journal/in-print/volume-108/volume-108-issue-6-june-2020/informed-consent-and-medical-artificial-intelligence-what-to-tell-the-patient/

[5] R. of Indonesia, Law Number 17 of 2023 concerning Health. 2023. [Online]. Available: https://peraturan.bpk.go.id/details/258028/uu-no-17-tahun-2023

[6] Indonesian Law Number 27 of 2022 concerning Personal Data Protection.

[7] Indonesian Law Number 11 of 2008 concerning Electronic Information and Transactions.

[8] Indonesian Law Number 8 of 1999 concerning Consumer Protection.

[9] B. Goodman and S. Flaxman, “European Union regulations on algorithmic decision-making and a right to explanation,” 2017.

[10] S. Wachter, B. Mittelstadt, and C. Russell, “Counterfactual explanations without opening the black box: automated decisions and the GDPR,” Harv. J. Law Technol., vol. 31, no. 2, pp. 841–887, 2018, [Online]. Available: https://jolt.law.harvard.edu/assets/articlePDFs/v31/Counterfactual-Explanations-without-Opening-the-Black-Box-Sandra-Wachter-et-al.pdf

[11] W. H. Organization, “Ethics and governance of artificial intelligence for health: WHO guidance,” World Health Organization, 2021. [Online]. Available: https://www.who.int/publications/i/item/9789240029200

[12] E. Parliament and C. of the E. Union, Regulation (EU) 2024/1689 laying down harmonised rules on artificial intelligence (Artificial Intelligence Act). 2024. [Online]. Available: https://eur-lex.europa.eu/eli/reg/2024/1689/oj/eng

[13] A. Jobin, M. Ienca, and E. Vayena, “The global landscape of AI ethics guidelines,” 2019.

[14] B. Mittelstadt, “Principles alone cannot guarantee ethical AI,” 2019.

[15] S. P. D. P. Commission, “Model Artificial Intelligence Governance Framework: Second Edition,” Personal Data Protection Commission Singapore, 2020. [Online]. Available: https://www.pdpc.gov.sg/organisations/resources/guidance-by-topic/singapores-approach-to-ai-governance